European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading

MT Newswires Live00:05

European equities traded in the US as American depositary receipts were tracking higher late Thursday morning, rising 0.63% to 1,651.45 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by 3D printer company Materialise (MTLS) and accommodations booking site trivago (TRVG), which rose 5.6% and 4.8%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and semiconductor company Sequans Communications (SQNS), which increased 3.9% and 2%, respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and furniture manufacturer Natuzzi (NTZ), which dropped 6.6% and 5%, respectively. They were followed by biopharmaceutical company argenx (ARGX) and pharmaceutical company Ascendis Pharma (ASND), which lost 1.4% and 1.1%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Mereo BioPharma Group (MREO), which advanced 4.1% and 2.9%, respectively. They were followed by biopharmaceutical company Amarin (AMRN) and lender Barclays (BCS), which were up 1.8% and 1.6%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which fell 21% and 7.5%, respectively. They were followed by oil and gas company BP (BP) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were down 2% each.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment